Literature DB >> 16518056

Gene expression profiling of breast cancer.

Koichi Nagasaki1, Yoshio Miki.   

Abstract

Numerous genes are controlled by complex regulatory networks and involved in the development and progression of breast cancer, and these genes are the key factors determining each characteristic of the tumor. Gene expression profiling, a large scale analysis of gene expression, has created new possibilities for the molecular characterization of cancer. Systematic analysis of expression patterns of thousands of genes in tumor cells using DNA microarrays and correlation of these patterns to specific features of phenotypic variation may provide the basis for an improved taxonomy of cancer. These profiles have the potential to explain the genetic heterogeneity of breast cancer and allow treatment strategies to be planned in accordance with their probability of success in individual patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518056     DOI: 10.2325/jbcs.13.2

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  8 in total

1.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

2.  Killer cell immunoglobulin-like receptor genes in patients with breast cancer.

Authors:  Ozlem Goruroglu Ozturk; Faik Deniz Gun; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-04-09       Impact factor: 3.064

Review 3.  Adenoviral vectors for prodrug activation-based gene therapy for cancer.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

4.  Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.

Authors:  J C Doloff; Y Jounaidi; D J Waxman
Journal:  Cancer Gene Ther       Date:  2010-09-24       Impact factor: 5.987

5.  Identifying causal genes and dysregulated pathways in complex diseases.

Authors:  Yoo-Ah Kim; Stefan Wuchty; Teresa M Przytycka
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

6.  FKBPL: a marker of good prognosis in breast cancer.

Authors:  Laura Nelson; Hayley D McKeen; Andrea Marshall; Laoighse Mulrane; Jane Starczynski; Sarah J Storr; Fiona Lanigan; Christopher Byrne; Ken Arthur; Shauna Hegarty; Ahlam Abdunnabi Ali; Fiona Furlong; Helen O McCarthy; Ian O Ellis; Andrew R Green; Emad Rakha; Leonie Young; Ian Kunkler; Jeremy Thomas; Wilma Jack; David Cameron; Karin Jirström; Anita Yakkundi; Lana McClements; Stewart G Martin; William M Gallagher; Janet Dunn; John Bartlett; Darran O'Connor; Tracy Robson
Journal:  Oncotarget       Date:  2015-05-20

7.  The role of talin2 in breast cancer tumorigenesis and metastasis.

Authors:  Liqing Li; Xiang Li; Lei Qi; Piotr Rychahou; Naser Jafari; Cai Huang
Journal:  Oncotarget       Date:  2017-11-06

8.  Selection strategy and the design of hybrid oligonucleotide primers for RACE-PCR: cloning a family of toxin-like sequences from Agelena orientalis.

Authors:  Zhensheng Pan; Richard Barry; Alexey Lipkin; Mikhail Soloviev
Journal:  BMC Mol Biol       Date:  2007-05-11       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.